Translational Research Committee

The Translational Research Committee (TRC) oversees AGITG’s new Translational Research (TR) Program. Its members are experts in the fields of biological research, medical oncology, surgery and pathology.

The TRC’s key role is to direct the new TR program, be actively involved in developing TR substudies as part of AGITG trials and review access requests from researchers to existing AGITG biospecimens. The Committee’s open dialogue leads to the development of a common language, interaction and commitment to translational research by a broad range of medical specialists, researchers and consumers.

Established in early 2022, the TRC represent a group of people who share a common goal: to improve GI cancer patient care through innovative translational research.

The AGITG TRC is elected in accordance with the AGITG Constitution, Terms of Reference can be found here.


Meet our TRC members

Share

Chair

A/Professor Vicki Whitehall
Translational Researcher

Deputy Chair

A/Professor Oliver Sieber
Translational Researcher

Members

Mr Jeff Cuff
Consumer Representative

A/Professor Nick Clemons
Translational Researcher

Dr Ben Dwyer
Translational Researcher

Dr Angela Chou
Translational Researcher/Pathologist

Dr Chris Nahm
Translational Researcher/Surgeon

Dr Connie Diakos
Translational Researcher/Medical Oncologist

Dr Vanessa Bonazzi
Translational Researcher

Dr Silke Neumann
Translational Researcher

Dr Ashleigh Poh
Translational Researcher

Dr Sarah Maloney
Translational Researcher/Medical Oncologist

Dr Sharon Pattison
Translational Researcher/Medical Oncologist

Dr Daniel Cox
Translational Researcher/Surgeon

Dr Sina Vatandoust
Translational Researcher/Medical Oncologist